Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1)

 M3K1_HUMAN              Reviewed;        1512 AA.
Q13233;
01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
16-DEC-2008, sequence version 4.
07-NOV-2018, entry version 187.
RecName: Full=Mitogen-activated protein kinase kinase kinase 1;
EC=2.7.11.25;
AltName: Full=MAPK/ERK kinase kinase 1;
Short=MEK kinase 1;
Short=MEKK 1;
Name=MAP3K1; Synonyms=MAPKKK1, MEKK, MEKK1;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15372022; DOI=10.1038/nature02919;
Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
"The DNA sequence and comparative analysis of human chromosome 5.";
Nature 431:268-274(2004).
[2]
NUCLEOTIDE SEQUENCE [MRNA] OF 20-1512, FUNCTION, AND INTERACTION WITH
MAP2K4.
PubMed=9808624; DOI=10.1101/gad.12.21.3369;
Xia Y., Wu Z., Su B., Murray B., Karin M.;
"JNKK1 organizes a MAP kinase module through specific and sequential
interactions with upstream and downstream components mediated by its
amino-terminal extension.";
Genes Dev. 12:3369-3381(1998).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1238-1274.
TISSUE=Leukocyte;
PubMed=8597633; DOI=10.1007/BF00539003;
Vinik B.S., Kay E.S., Fiedorek F.T. Jr.;
"Mapping of the MEK kinase gene (Mekk) to mouse chromosome 13 and
human chromosome 5.";
Mamm. Genome 6:782-783(1995).
[4]
INTERACTION WITH AXIN1.
PubMed=12223491; DOI=10.1074/jbc.M208099200;
Rui H.L., Fan E., Zhou H.M., Xu Z., Zhang Y., Lin S.C.;
"SUMO-1 modification of the C-terminal KVEKVD of Axin is required for
JNK activation but has no effect on Wnt signaling.";
J. Biol. Chem. 277:42981-42986(2002).
[5]
INTERACTION WITH AXIN1.
PubMed=15262978; DOI=10.1074/jbc.M404598200;
Wong C.K., Luo W., Deng Y., Zou H., Ye Z., Lin S.-C.;
"The DIX domain protein coiled-coil-DIX1 inhibits c-Jun N-terminal
kinase activation by Axin and dishevelled through distinct
mechanisms.";
J. Biol. Chem. 279:39366-39373(2004).
[6]
FUNCTION, AND INTERACTION WITH GRIPAP1.
PubMed=17761173; DOI=10.1016/j.febslet.2007.08.008;
Ye B., Yu W.P., Thomas G.M., Huganir R.L.;
"GRASP-1 is a neuronal scaffold protein for the JNK signaling
pathway.";
FEBS Lett. 581:4403-4410(2007).
[7]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18220336; DOI=10.1021/pr0705441;
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
Yates J.R. III;
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
efficient phosphoproteomic analysis.";
J. Proteome Res. 7:1346-1351(2008).
[8]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154 AND SER-1043, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
Greff Z., Keri G., Stemmann O., Mann M.;
"Kinase-selective enrichment enables quantitative phosphoproteomics of
the kinome across the cell cycle.";
Mol. Cell 31:438-448(2008).
[9]
INTERACTION WITH STK38.
PubMed=17906693; DOI=10.1038/sj.onc.1210828;
Enomoto A., Kido N., Ito M., Morita A., Matsumoto Y., Takamatsu N.,
Hosoi Y., Miyagawa K.;
"Negative regulation of MEKK1/2 signaling by serine-threonine kinase
38 (STK38).";
Oncogene 27:1930-1938(2008).
[10]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292; SER-297; SER-300;
SER-507 AND SER-1018, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18669648; DOI=10.1073/pnas.0805139105;
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
Elledge S.J., Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
[11]
ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19413330; DOI=10.1021/ac9004309;
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
Mohammed S.;
"Lys-N and trypsin cover complementary parts of the phosphoproteome in
a refined SCX-based approach.";
Anal. Chem. 81:4493-4501(2009).
[12]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275 AND SER-292, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
Mann M., Daub H.;
"Large-scale proteomics analysis of the human kinome.";
Mol. Cell. Proteomics 8:1751-1764(2009).
[13]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-35; SER-275;
THR-285; SER-292; SER-531; SER-923 AND SER-1018, AND IDENTIFICATION BY
MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma, and Erythroleukemia;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
[14]
VARIANTS [LARGE SCALE ANALYSIS] ASN-92 AND SER-443.
PubMed=17344846; DOI=10.1038/nature05610;
Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
"Patterns of somatic mutation in human cancer genomes.";
Nature 446:153-158(2007).
[15]
VARIANTS SRXY6 PRO-189; ARG-189; ILE-GLN-211 INS AND ARG-616, AND
CHARACTERIZATION OF VARIANTS SRXY6 PRO-189 AND ARG-189.
PubMed=21129722; DOI=10.1016/j.ajhg.2010.11.003;
Pearlman A., Loke J., Le Caignec C., White S., Chin L., Friedman A.,
Warr N., Willan J., Brauer D., Farmer C., Brooks E., Oddoux C.,
Riley B., Shajahan S., Camerino G., Homfray T., Crosby A.H.,
Couper J., David A., Greenfield A., Sinclair A., Ostrer H.;
"Mutations in MAP3K1 cause 46,XY disorders of sex development and
implicate a common signal transduction pathway in human testis
determination.";
Am. J. Hum. Genet. 87:898-904(2010).
-!- FUNCTION: Component of a protein kinase signal transduction
cascade (PubMed:9808624). Activates the ERK and JNK kinase
pathways by phosphorylation of MAP2K1 and MAP2K4 (PubMed:9808624).
May phosphorylate the MAPK8/JNK1 kinase (PubMed:17761173).
Activates CHUK and IKBKB, the central protein kinases of the NF-
kappa-B pathway (PubMed:9808624). {ECO:0000269|PubMed:17761173,
ECO:0000269|PubMed:9808624}.
-!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
-!- COFACTOR:
Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
-!- ACTIVITY REGULATION: Activated by autophosphorylation on Thr-1400
and Thr-1412 following oligomerization.
-!- SUBUNIT: Binds both upstream activators and downstream substrates
in multimolecular complexes through its N-terminus
(PubMed:9808624). Oligomerizes after binding MAP2K4 or TRAF2
(PubMed:9808624). Interacts with AXIN1 (PubMed:12223491,
PubMed:15262978). Interacts (via the kinase catalytic domain) with
STK38 (PubMed:17906693). Interacts with GRIPAP1 (PubMed:17761173).
{ECO:0000269|PubMed:12223491, ECO:0000269|PubMed:15262978,
ECO:0000269|PubMed:17761173, ECO:0000269|PubMed:17906693,
ECO:0000269|PubMed:9808624}.
-!- INTERACTION:
P32121:ARRB2; NbExp=2; IntAct=EBI-49776, EBI-714559;
P15056:BRAF; NbExp=2; IntAct=EBI-49776, EBI-365980;
P61962:DCAF7; NbExp=7; IntAct=EBI-49776, EBI-359808;
O75369:FLNB; NbExp=2; IntAct=EBI-49776, EBI-352089;
P45985:MAP2K4; NbExp=3; IntAct=EBI-49776, EBI-447868;
Q12851:MAP4K2; NbExp=2; IntAct=EBI-49776, EBI-49783;
Q12933:TRAF2; NbExp=2; IntAct=EBI-49776, EBI-355744;
-!- PTM: Autophosphorylated. {ECO:0000250}.
-!- DISEASE: 46,XY sex reversal 6 (SRXY6) [MIM:613762]: A disorder of
sex development. Affected individuals have a 46,XY karyotype but
present as phenotypically normal females.
{ECO:0000269|PubMed:21129722}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
protein kinase family. MAP kinase kinase kinase subfamily.
{ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AC008937; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AF042838; AAC97073.1; -; mRNA.
EMBL; U29671; AAB05828.1; -; Genomic_DNA.
CCDS; CCDS43318.1; -.
PIR; G01887; G01887.
RefSeq; NP_005912.1; NM_005921.1.
UniGene; Hs.653654; -.
ProteinModelPortal; Q13233; -.
SMR; Q13233; -.
BioGrid; 110378; 138.
DIP; DIP-27520N; -.
ELM; Q13233; -.
IntAct; Q13233; 39.
MINT; Q13233; -.
STRING; 9606.ENSP00000382423; -.
BindingDB; Q13233; -.
ChEMBL; CHEMBL3956; -.
DrugBank; DB06061; AZD-8330.
GuidetoPHARMACOLOGY; 2069; -.
iPTMnet; Q13233; -.
PhosphoSitePlus; Q13233; -.
BioMuta; MAP3K1; -.
DMDM; 218512139; -.
SWISS-2DPAGE; Q13233; -.
EPD; Q13233; -.
MaxQB; Q13233; -.
PaxDb; Q13233; -.
PeptideAtlas; Q13233; -.
PRIDE; Q13233; -.
ProteomicsDB; 59240; -.
DNASU; 4214; -.
Ensembl; ENST00000399503; ENSP00000382423; ENSG00000095015.
GeneID; 4214; -.
KEGG; hsa:4214; -.
UCSC; uc003jqw.5; human.
CTD; 4214; -.
DisGeNET; 4214; -.
EuPathDB; HostDB:ENSG00000095015.5; -.
GeneCards; MAP3K1; -.
GeneReviews; MAP3K1; -.
H-InvDB; HIX0024789; -.
HGNC; HGNC:6848; MAP3K1.
HPA; CAB004500; -.
HPA; HPA046509; -.
MalaCards; MAP3K1; -.
MIM; 600982; gene.
MIM; 613762; phenotype.
neXtProt; NX_Q13233; -.
OpenTargets; ENSG00000095015; -.
Orphanet; 242; 46,XY complete gonadal dysgenesis.
Orphanet; 251510; 46,XY partial gonadal dysgenesis.
PharmGKB; PA30592; -.
eggNOG; KOG4279; Eukaryota.
eggNOG; ENOG410XQGS; LUCA.
GeneTree; ENSGT00800000124036; -.
HOGENOM; HOG000113437; -.
HOVERGEN; HBG006302; -.
InParanoid; Q13233; -.
KO; K04416; -.
OMA; NAVIPSD; -.
OrthoDB; EOG091G03WB; -.
PhylomeDB; Q13233; -.
TreeFam; TF105112; -.
Reactome; R-HSA-166058; MyD88:Mal cascade initiated on plasma membrane.
Reactome; R-HSA-2871796; FCERI mediated MAPK activation.
Reactome; R-HSA-933542; TRAF6 mediated NF-kB activation.
Reactome; R-HSA-975138; TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation.
Reactome; R-HSA-975871; MyD88 cascade initiated on plasma membrane.
SignaLink; Q13233; -.
SIGNOR; Q13233; -.
ChiTaRS; MAP3K1; human.
GeneWiki; MAP3K1; -.
GenomeRNAi; 4214; -.
PRO; PR:Q13233; -.
Proteomes; UP000005640; Chromosome 5.
Bgee; ENSG00000095015; Expressed in 213 organ(s), highest expression level in blood.
CleanEx; HS_MAP3K1; -.
Genevisible; Q13233; HS.
GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
GO; GO:0005829; C:cytosol; TAS:Reactome.
GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
GO; GO:0004709; F:MAP kinase kinase kinase activity; NAS:UniProtKB.
GO; GO:0004672; F:protein kinase activity; IDA:MGI.
GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
GO; GO:0032147; P:activation of protein kinase activity; IBA:GO_Central.
GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB.
GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
GO; GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome.
GO; GO:0006468; P:protein phosphorylation; NAS:UniProtKB.
GO; GO:0023014; P:signal transduction by protein phosphorylation; IBA:GO_Central.
GO; GO:0031098; P:stress-activated protein kinase signaling cascade; IBA:GO_Central.
Gene3D; 1.25.10.10; -; 1.
Gene3D; 3.30.40.10; -; 1.
InterPro; IPR011989; ARM-like.
InterPro; IPR016024; ARM-type_fold.
InterPro; IPR011009; Kinase-like_dom_sf.
InterPro; IPR000719; Prot_kinase_dom.
InterPro; IPR017441; Protein_kinase_ATP_BS.
InterPro; IPR008271; Ser/Thr_kinase_AS.
InterPro; IPR001841; Znf_RING.
InterPro; IPR013083; Znf_RING/FYVE/PHD.
InterPro; IPR007527; Znf_SWIM.
Pfam; PF00069; Pkinase; 1.
SMART; SM00220; S_TKc; 1.
SUPFAM; SSF48371; SSF48371; 1.
SUPFAM; SSF56112; SSF56112; 1.
PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PROSITE; PS50089; ZF_RING_2; 1.
PROSITE; PS50966; ZF_SWIM; 1.
1: Evidence at protein level;
Acetylation; ATP-binding; Complete proteome; Kinase; Magnesium;
Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
Reference proteome; Serine/threonine-protein kinase; Transferase;
Zinc; Zinc-finger.
INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330}.
CHAIN 2 1512 Mitogen-activated protein kinase kinase
kinase 1.
/FTId=PRO_0000086240.
DOMAIN 1243 1508 Protein kinase. {ECO:0000255|PROSITE-
ProRule:PRU00159}.
ZN_FING 338 366 SWIM-type. {ECO:0000255|PROSITE-
ProRule:PRU00325}.
ZN_FING 443 492 RING-type. {ECO:0000255|PROSITE-
ProRule:PRU00175}.
NP_BIND 1249 1257 ATP. {ECO:0000255|PROSITE-
ProRule:PRU00159}.
COMPBIAS 2 5 Poly-Ala.
COMPBIAS 25 29 Poly-Gly.
COMPBIAS 36 41 Poly-Ala.
COMPBIAS 422 431 Poly-Ser.
COMPBIAS 842 847 Poly-Ser.
COMPBIAS 942 949 Poly-Thr.
COMPBIAS 1182 1187 Poly-Glu.
COMPBIAS 1216 1219 Poly-Ile.
ACT_SITE 1369 1369 Proton acceptor. {ECO:0000255|PROSITE-
ProRule:PRU00159, ECO:0000255|PROSITE-
ProRule:PRU10027}.
BINDING 1272 1272 ATP. {ECO:0000255|PROSITE-
ProRule:PRU00159}.
MOD_RES 2 2 N-acetylalanine.
{ECO:0000244|PubMed:19413330}.
MOD_RES 21 21 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 35 35 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 137 137 Phosphoserine.
{ECO:0000250|UniProtKB:P53349}.
MOD_RES 154 154 Phosphoserine.
{ECO:0000244|PubMed:18691976}.
MOD_RES 275 275 Phosphoserine.
{ECO:0000244|PubMed:19369195,
ECO:0000244|PubMed:23186163}.
MOD_RES 285 285 Phosphothreonine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 292 292 Phosphoserine.
{ECO:0000244|PubMed:18220336,
ECO:0000244|PubMed:18669648,
ECO:0000244|PubMed:19369195,
ECO:0000244|PubMed:23186163}.
MOD_RES 297 297 Phosphoserine.
{ECO:0000244|PubMed:18669648}.
MOD_RES 300 300 Phosphoserine.
{ECO:0000244|PubMed:18669648}.
MOD_RES 507 507 Phosphoserine.
{ECO:0000244|PubMed:18669648}.
MOD_RES 531 531 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 923 923 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 1018 1018 Phosphoserine.
{ECO:0000244|PubMed:18669648,
ECO:0000244|PubMed:23186163}.
MOD_RES 1043 1043 Phosphoserine.
{ECO:0000244|PubMed:18691976}.
MOD_RES 1400 1400 Phosphothreonine; by autocatalysis.
{ECO:0000250|UniProtKB:P53349}.
MOD_RES 1412 1412 Phosphothreonine; by autocatalysis.
{ECO:0000250|UniProtKB:P53349}.
VARIANT 92 92 S -> N. {ECO:0000269|PubMed:17344846}.
/FTId=VAR_040680.
VARIANT 189 189 L -> P (in SRXY6; increases
phosphorylation of the downstream target
MAPK3/MAPK1 compared to wild-type and
enhances binding of RHOA to the mutant
MAP3K1 complex; dbSNP:rs387906788).
{ECO:0000269|PubMed:21129722}.
/FTId=VAR_065504.
VARIANT 189 189 L -> R (in SRXY6; increases
phosphorylation of the downstream targets
MAPK14 and MAPK3/MAPK1 compared to wild-
type and enhances binding of RHOA to the
mutant MAP3K1 complex;
dbSNP:rs387906788).
{ECO:0000269|PubMed:21129722}.
/FTId=VAR_065505.
VARIANT 211 211 V -> VIQ (in SRXY6).
/FTId=VAR_065506.
VARIANT 443 443 C -> S. {ECO:0000269|PubMed:17344846}.
/FTId=VAR_040681.
VARIANT 616 616 G -> R (in SRXY6; dbSNP:rs143853590).
{ECO:0000269|PubMed:21129722}.
/FTId=VAR_065507.
VARIANT 806 806 D -> N (in dbSNP:rs702689).
/FTId=VAR_051636.
VARIANT 906 906 V -> I (in dbSNP:rs832582).
/FTId=VAR_051637.
CONFLICT 20 20 T -> P (in Ref. 2; AAC97073).
{ECO:0000305}.
CONFLICT 37 37 P -> R (in Ref. 2; AAC97073).
{ECO:0000305}.
CONFLICT 120 120 G -> R (in Ref. 2; AAC97073).
{ECO:0000305}.
CONFLICT 351 351 R -> H (in Ref. 2; AAC97073).
{ECO:0000305}.
CONFLICT 845 845 S -> SV (in Ref. 2; AAC97073).
{ECO:0000305}.
CONFLICT 859 859 I -> Y (in Ref. 2; AAC97073).
{ECO:0000305}.
CONFLICT 878 902 DGQQDSFLQASVPNNYLETTENSSP -> QRQQHNSFCRHL
FPTTIWKPQRTVPL (in Ref. 2; AAC97073).
{ECO:0000305}.
CONFLICT 933 933 S -> R (in Ref. 2; AAC97073).
{ECO:0000305}.
CONFLICT 1097 1097 C -> L (in Ref. 2; AAC97073).
{ECO:0000305}.
CONFLICT 1104 1107 AVIP -> CCYT (in Ref. 2; AAC97073).
{ECO:0000305}.
CONFLICT 1200 1200 D -> V (in Ref. 2; AAC97073).
{ECO:0000305}.
SEQUENCE 1512 AA; 164470 MW; 5CB78242295411D9 CRC64;
MAAAAGNRAS SSGFPGARAT SPEAGGGGGA LKASSAPAAA AGLLREAGSG GRERADWRRR
QLRKVRSVEL DQLPEQPLFL AASPPASSTS PSPEPADAAG SGTGFQPVAV PPPHGAASRG
GAHLTESVAA PDSGASSPAA AEPGEKRAPA AEPSPAAAPA GREMENKETL KGLHKMDDRP
EERMIREKLK ATCMPAWKHE WLERRNRRGP VVVKPIPVKG DGSEMNHLAA ESPGEVQASA
ASPASKGRRS PSPGNSPSGR TVKSESPGVR RKRVSPVPFQ SGRITPPRRA PSPDGFSPYS
PEETNRRVNK VMRARLYLLQ QIGPNSFLIG GDSPDNKYRV FIGPQNCSCA RGTFCIHLLF
VMLRVFQLEP SDPMLWRKTL KNFEVESLFQ KYHSRRSSRI KAPSRNTIQK FVSRMSNSHT
LSSSSTSTSS SENSIKDEEE QMCPICLLGM LDEESLTVCE DGCRNKLHHH CMSIWAEECR
RNREPLICPL CRSKWRSHDF YSHELSSPVD SPSSLRAAQQ QTVQQQPLAG SRRNQESNFN
LTHYGTQQIP PAYKDLAEPW IQVFGMELVG CLFSRNWNVR EMALRRLSHD VSGALLLANG
ESTGNSGGSS GSSPSGGATS GSSQTSISGD VVEACCSVLS MVCADPVYKV YVAALKTLRA
MLVYTPCHSL AERIKLQRLL QPVVDTILVK CADANSRTSQ LSISTLLELC KGQAGELAVG
REILKAGSIG IGGVDYVLNC ILGNQTESNN WQELLGRLCL IDRLLLEFPA EFYPHIVSTD
VSQAEPVEIR YKKLLSLLTF ALQSIDNSHS MVGKLSRRIY LSSARMVTTV PHVFSKLLEM
LSVSSSTHFT RMRRRLMAIA DEVEIAEAIQ LGVEDTLDGQ QDSFLQASVP NNYLETTENS
SPECTVHLEK TGKGLCATKL SASSEDISER LASISVGPSS STTTTTTTTE QPKPMVQTKG
RPHSQCLNSS PLSHHSQLMF PALSTPSSST PSVPAGTATD VSKHRLQGFI PCRIPSASPQ
TQRKFSLQFH RNCPENKDSD KLSPVFTQSR PLPSSNIHRP KPSRPTPGNT SKQGDPSKNS
MTLDLNSSSK CDDSFGCSSN SSNAVIPSDE TVFTPVEEKC RLDVNTELNS SIEDLLEASM
PSSDTTVTFK SEVAVLSPEK AENDDTYKDD VNHNQKCKEK MEAEEEEALA IAMAMSASQD
ALPIVPQLQV ENGEDIIIIQ QDTPETLPGH TKAKQPYRED TEWLKGQQIG LGAFSSCYQA
QDVGTGTLMA VKQVTYVRNT SSEQEEVVEA LREEIRMMSH LNHPNIIRML GATCEKSNYN
LFIEWMAGGS VAHLLSKYGA FKESVVINYT EQLLRGLSYL HENQIIHRDV KGANLLIDST
GQRLRIADFG AAARLASKGT GAGEFQGQLL GTIAFMAPEV LRGQQYGRSC DVWSVGCAII
EMACAKPPWN AEKHSNHLAL IFKIASATTA PSIPSHLSPG LRDVALRCLE LQPQDRPPSR
ELLKHPVFRT TW


Related products :

Catalog number Product name Quantity
E1358m ELISA kit Apoptosis signal-regulating kinase 1,Ask1,ASK-1,Map3k5,MAPK_ERK kinase kinase 5,MEK kinase 5,MEKK 5,Mekk5,Mitogen-activated protein kinase kinase kinase 5,Mouse,Mus musculus 96T
U1358m CLIA Apoptosis signal-regulating kinase 1,Ask1,ASK-1,Map3k5,MAPK_ERK kinase kinase 5,MEK kinase 5,MEKK 5,Mekk5,Mitogen-activated protein kinase kinase kinase 5,Mouse,Mus musculus 96T
E1358m ELISA Apoptosis signal-regulating kinase 1,Ask1,ASK-1,Map3k5,MAPK_ERK kinase kinase 5,MEK kinase 5,MEKK 5,Mekk5,Mitogen-activated protein kinase kinase kinase 5,Mouse,Mus musculus 96T
E1358h ELISA kit Apoptosis signal-regulating kinase 1,ASK1,ASK-1,Homo sapiens,Human,MAP3K5,MAPK_ERK kinase kinase 5,MAPKKK5,MEK kinase 5,MEKK 5,MEKK5,Mitogen-activated protein kinase kinase kinase 5 96T
U1358h CLIA Apoptosis signal-regulating kinase 1,ASK1,ASK-1,Homo sapiens,Human,MAP3K5,MAPK_ERK kinase kinase 5,MAPKKK5,MEK kinase 5,MEKK 5,MEKK5,Mitogen-activated protein kinase kinase kinase 5 96T
E1358h ELISA Apoptosis signal-regulating kinase 1,ASK1,ASK-1,Homo sapiens,Human,MAP3K5,MAPK_ERK kinase kinase 5,MAPKKK5,MEK kinase 5,MEKK 5,MEKK5,Mitogen-activated protein kinase kinase kinase 5 96T
EIAAB25244 c-Jun N-terminal kinase kinase 2,Dual specificity mitogen-activated protein kinase kinase 7,JNK kinase 2,JNK-activating kinase 2,JNKK 2,MAP kinase kinase 7,Map2k7,MAPK_ERK kinase 7,MAPKK 7,MEK 7,Mkk7,
EIAAB25239 C-JUN N-terminal kinase kinase 1,Dual specificity mitogen-activated protein kinase kinase 4,JNK kinase 1,JNK-activating kinase 1,JNKK 1,Jnkk1,MAP kinase kinase 4,Map2k4,MAPK_ERK kinase 4,MAPKK 4,MEK 4
EIAAB25245 c-Jun N-terminal kinase kinase 2,Dual specificity mitogen-activated protein kinase kinase 7,JNK kinase 2,JNK-activating kinase 2,JNKK 2,MAP kinase kinase 7,Map2k7,MAPK_ERK kinase 7,MAPKK 7,MEK 7,Rat,R
EIAAB24784 GCK family kinase MiNK,Map4k6,MAPK_ERK kinase kinase kinase 6,MEK kinase kinase 6,MEKKK 6,Mink,Mink1,Misshapen_NIK-related kinase,Misshapen-like kinase 1,Mitogen-activated protein kinase kinase kinase
EIAAB24783 GCK family kinase MiNK,Map4k6,MAPK_ERK kinase kinase kinase 6,MEK kinase kinase 6,MEKKK 6,Mink,Mink1,Misshapen_NIK-related kinase,Misshapen-like kinase 1,Mitogen-activated protein kinase kinase kinase
E1206r ELISA kit Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protei 96T
E1206m ELISA kit Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protei 96T
E1206h ELISA kit ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,Homo sapiens,Human,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-ac 96T
E1206h ELISA ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,Homo sapiens,Human,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-activat 96T
U1206h CLIA ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,Homo sapiens,Human,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-activate 96T
U1206m CLIA Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protein kina 96T
U1206r CLIA Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protein kina 96T
EIAAB25246 c-Jun N-terminal kinase kinase 2,Dual specificity mitogen-activated protein kinase kinase 7,Homo sapiens,Human,JNK kinase 2,JNK-activating kinase 2,JNKK 2,JNKK2,MAP kinase kinase 7,MAP2K7,MAPK_ERK kin
U1206b CLIA Bos taurus,Bovine,ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-activated protein kinase 2,PRKM1 96T
E1206b ELISA Bos taurus,Bovine,ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-activated protein kinase 2,PRKM 96T
EIAAB25240 c-Jun N-terminal kinase kinase 1,Dual specificity mitogen-activated protein kinase kinase 4,Homo sapiens,Human,JNK-activating kinase 1,JNKK,JNKK1,MAP kinase kinase 4,MAP2K4,MAPK_ERK kinase 4,MAPKK 4,M
E1206m ELISA Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protein kin 96T
E1206r ELISA Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protein kin 96T
E1206b ELISA kit Bos taurus,Bovine,ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-activated protein kinase 2 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur